Table 3. The relationship between nodal status and Galectin-4 expression in each subtype.
Galectin-4 positive | Galectin-4 negative | Correlation χ2 (p) | |
no. cases (%) | no. cases (%) | ||
All invasive adenocarcinomas | 0.02701 | ||
N0 | 103 (22.3) | 358 (77.7) | |
N1/N2 | 43 (31.6) | 93 (68.4) | |
Lepidic predominant | 0.3605 | ||
N0 | 34 (17.3) | 162 (82.7) | |
N1/N2 | 0 (0.0) | 4(100.0) | |
Acinar predominant | <0.0001 | ||
N0 | 33 (21.0) | 124 (79.0) | |
N1/N2 | 27 (50.0) | 27 (50.0) | |
Papillary predominant | 0.776 | ||
N0 | 12 (26.1) | 34 (73.9) | |
N1/N2 | 9 (29.0) | 22 (71.0) | |
Solid predominant | 0.6521 | ||
N0 | 3 (9.7) | 28 (90.3) | |
N1/N2 | 6 (13.0) | 40 (87.0) |